Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes

NCT05266963 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05266963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05266963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
September 2, 2022
Completion date
March 22, 2024
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes